555 related articles for article (PubMed ID: 17235712)
1. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Washington University Head and Neck Comorbidity Index in a cohort of older patients.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):603-7. PubMed ID: 18559726
[TBL] [Abstract][Full Text] [Related]
3. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
4. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
5. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
Castro MA; Dedivitis RA; Ribeiro KC
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
[TBL] [Abstract][Full Text] [Related]
7. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
[TBL] [Abstract][Full Text] [Related]
9. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma.
Singh B; Bhaya M; Zimbler M; Stern J; Roland JT; Rosenfeld RM; Har-El G; Lucente FE
Head Neck; 1998 Jan; 20(1):1-7. PubMed ID: 9464945
[TBL] [Abstract][Full Text] [Related]
10. Factors that influence treatment decision in older patients with resectable head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Laryngoscope; 2007 May; 117(5):835-40. PubMed ID: 17473679
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of comorbidity in salivary gland carcinoma.
Terhaard CH; van der Schroeff MP; van Schie K; Eerenstein SE; Lubsen H; Kaanders JH; Smeele LE; Burlage FR; van Den Ende PL; Baatenburg de Jong RJ
Cancer; 2008 Oct; 113(7):1572-9. PubMed ID: 18704992
[TBL] [Abstract][Full Text] [Related]
12. Head and neck cancer in the elderly: a cohort study in 40 patients.
Sesterhenn AM; Teymoortash A; Folz BJ; Werner JA
Acta Oncol; 2005; 44(1):59-64. PubMed ID: 15848907
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
14. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.
Lau H; Phan T; Mackinnon J; Matthews TW
Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):257-61. PubMed ID: 18347249
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma.
Preuss SF; Klussmann JP; Wittekindt C; Damm M; Semrau R; Drebber U; Guntinas-Lichius O
Eur J Surg Oncol; 2007 Apr; 33(3):358-63. PubMed ID: 17157472
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
Dietl B; Marienhagen J; Schäfer C; Kölbl O
Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
[TBL] [Abstract][Full Text] [Related]
17. The impact of comorbidity and age on survival with laryngeal cancer.
Sabin SL; Rosenfeld RM; Sundaram K; Har-el G; Lucente FE
Ear Nose Throat J; 1999 Aug; 78(8):578, 581-4. PubMed ID: 10485151
[TBL] [Abstract][Full Text] [Related]
18. Measuring comorbidity in patients with head and neck cancer.
Hall SF; Rochon PA; Streiner DL; Paszat LF; Groome PA; Rohland SL
Laryngoscope; 2002 Nov; 112(11):1988-96. PubMed ID: 12439168
[TBL] [Abstract][Full Text] [Related]
19. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
[TBL] [Abstract][Full Text] [Related]
20. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.
Datema FR; Ferrier MB; van der Schroeff MP; Baatenburg de Jong RJ
Head Neck; 2010 Jun; 32(6):728-36. PubMed ID: 19827120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
